Literature DB >> 19242609

Blood supply in melanoma xenografts is governed by the morphology of the supplying arteries.

Jon-Vidar Gaustad1, Trude G Simonsen, Kjetil G Brurberg, Else Marie Huuse, Einar K Rofstad.   

Abstract

Tumor blood supply was related to the morphology of the tumor microvasculature and the supplying arteries (SAs) of A-07-GFP and D-12-GFP melanoma xenografts growing in window chamber preparations in BALB/c nu/nu mice. Blood supply and morphologic parameters were determined from first-pass imaging movies and vascular maps recorded after a bolus of 155-kDa tetramethylrhodamine isothiocyanate-labeled dextran had been administered intravenously. Poorly supplied tumors showed microvascular networks that did not differ from those of well-supplied tumors in vessel tortuosity, diameter, and density. Conversely, the SAs of poorly supplied tumors were more tortuous and had a smaller diameter than those of well-supplied tumors, resulting in lower plasma velocities in the downstream tumor vessels. Consequently, the blood supply of A-07-GFP and D-12-GFP tumors was governed by the geometric resistance of the SAs rather than by the geometric resistance or the vessel density of the tumor microvasculature. The present study suggests that the SAs may represent an important target for physiological interventions of tumors and that it may be beneficial to focus on the tumor SAs rather than the tumor microvasculature when searching for novel therapeutic strategies for modifying tumor blood supply.

Entities:  

Mesh:

Year:  2009        PMID: 19242609      PMCID: PMC2647730          DOI: 10.1593/neo.81400

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  31 in total

Review 1.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Thrombospondin-1-mediated metastasis suppression by the primary tumor in human melanoma xenografts.

Authors:  E K Rofstad; B A Graff
Journal:  J Invest Dermatol       Date:  2001-11       Impact factor: 8.551

3.  Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.

Authors:  E K Rofstad; E F Halsør
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

Review 4.  Angiogenesis in cancer and other diseases.

Authors:  P Carmeliet; R K Jain
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

Review 5.  Microenvironment-induced cancer metastasis.

Authors:  E K Rofstad
Journal:  Int J Radiat Biol       Date:  2000-05       Impact factor: 2.694

Review 6.  Tumor microenvironmental physiology and its implications for radiation oncology.

Authors:  Peter Vaupel
Journal:  Semin Radiat Oncol       Date:  2004-07       Impact factor: 5.934

7.  Temporal heterogeneity in blood supply in human tumor xenografts.

Authors:  Kjetil G Brurberg; Jon-Vidar Gaustad; Camilla S Mollatt; Einar K Rofstad
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

Review 8.  Determinants of tumor blood flow: a review.

Authors:  R K Jain
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

9.  Mathematical modelling of oxygen supply and oxygenation in tumor tissues: prognostic, therapeutic, and experimental implications.

Authors:  F L Degner; R M Sutherland
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-08       Impact factor: 7.038

10.  Growth characteristics of human melanoma multicellular spheroids in liquid-overlay culture: comparisons with the parent tumour xenografts.

Authors:  E K Rofstad; A Wahl; C de L Davies; T Brustad
Journal:  Cell Tissue Kinet       Date:  1986-03
View more
  12 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia.

Authors:  Einar K Rofstad; Berit Mathiesen
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

3.  Spectral imaging reveals microvessel physiology and function from anastomoses to thromboses.

Authors:  Mamta Wankhede; Nikita Agarwal; Rodrigo A Fraga-Silva; Casey deDeugd; Mohan K Raizada; S Paul Oh; Brian S Sorg
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

4.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

5.  Monitoring the longitudinal intra-tumor physiological impulse response to VEGFR2 blockade in breast tumors using DCE-CT.

Authors:  Keith M Stantz; Minsong Cao; Ning Cao; Yun Liang; Kathy D Miller
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

6.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

7.  Radiocurability is associated with interstitial fluid pressure in human tumor xenografts.

Authors:  Einar K Rofstad; Jon-Vidar Gaustad; Kjetil G Brurberg; Berit Mathiesen; Kanthi Galappathi; Trude G Simonsen
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

8.  A bioimage informatics based reconstruction of breast tumor microvasculature with computational blood flow predictions.

Authors:  Spyros K Stamatelos; Eugene Kim; Arvind P Pathak; Aleksander S Popel
Journal:  Microvasc Res       Date:  2013-12-14       Impact factor: 3.514

9.  High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts.

Authors:  Trude G Simonsen; Jon-Vidar Gaustad; Marit N Leinaas; Einar K Rofstad
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts.

Authors:  Jon-Vidar Gaustad; Trude G Simonsen; Marit N Leinaas; Einar K Rofstad
Journal:  BMC Cancer       Date:  2012-09-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.